Interdisziplinäres Crohn Colitis Centrum Rhein-Main - iCCC
others
Location:
Frankfurt a.M.,
Germany (DE)
Aktualisierte S3-Leitlinie Colitis ulcerosa (Version 6.2) (2024)
Kucharzik T, Dignass A, Atreya R, Bokemeyer B, Esters P, Herrlinger K, Kannengiesser K, et al.
Journal article
Aktualisierte S3-Leitlinie Colitis ulcerosa (Version 6.1) - Februar 2023 - AWMF-Registriernummer: 021-009 (2023)
Kucharzik T, Dignass A, Atreya R, Bokemeyer B, Esters P, Herrlinger K, Kannengiesser K, et al.
Journal article
Comparative real-world effectiveness and persistence of vedolizumab versus anti-TNF therapy in biologic-naive patients with Crohn's Disease with Propensity Score adjustment: Maintenance phase results at week-52 from the prospective VEDOIBD study (2022)
Di Giuseppe R, Plachta-Danielzik S, Bokemeyer B, Efken P, Mohl W, Hoffstadt M, Krause T, et al.
Conference contribution
Updated S3-Guideline Ulcerative Colitis. German Society for Digestive and Metabolic Diseases (DGVS): AWMF Registry 021/009 (2019)
Kucharzik T, Dignass AU, Atreya R, Bokemeyer B, Esters P, Herrlinger K, Kannengiesser K, et al.
Journal article